tiprankstipranks
Advertisement
Advertisement

Recordati Calls 2026 Shareholders’ Meeting to Approve Results, Incentive Plan and New Capital Mandate

Story Highlights
  • Recordati will hold a fully remote shareholders’ meeting on 29 April 2026 to approve 2025 financials, appoint auditors, update remuneration policies and launch a new 2026–2028 performance share plan.
  • Shareholders will also vote on a board mandate to issue financial instruments up to 10% of capital and amend the articles, reinforcing Recordati’s flexibility in capital management and future funding strategies.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Recordati Calls 2026 Shareholders’ Meeting to Approve Results, Incentive Plan and New Capital Mandate

Meet Samuel – Your Personal Investing Prophet

Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an update.

Recordati has convened an ordinary and extraordinary shareholders’ meeting for 29 April 2026, to be held without physical attendance and with voting exercised exclusively via a designated representative in line with extended Italian emergency provisions. Shareholders will vote on approval of the 2025 financial statements and profit allocation, appointment and remuneration of the Board of Statutory Auditors, the remuneration policy report, a new 2026–2028 performance share incentive plan, and authorization to buy and dispose of treasury shares.

In the extraordinary session, investors will also consider granting the board a mandate to issue financial instruments within 10% of share capital and amend the company’s articles accordingly, potentially enhancing capital-management flexibility. The meeting structure, including reliance on a designated proxy and detailed proxy procedures, underscores continued regulatory-driven remote governance practices while enabling Recordati to update its incentive systems and financial tools, with implications for governance, shareholder returns, and future funding options.

The most recent analyst rating on (IT:REC) stock is a Buy with a EUR57.50 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company based in Milan, with a fully paid-in share capital of €26.1 million divided into over 209 million registered ordinary shares. The company focuses on producing and marketing pharmaceutical products and operates under the management and coordination of Rossini Luxembourg S.àr.l., with its shares carrying one vote each at shareholder meetings.

Average Trading Volume: 329,583

Technical Sentiment Signal: Hold

Current Market Cap: €9.18B

Learn more about REC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1